In vivo biocompatibility and degradability of a novel injectable-chitosan-based implant

Fwu Long Mi, Yu Chiun Tan, Hsiang F. Liang, Hsing W. Sung

Research output: Contribution to journalArticle

434 Citations (Scopus)

Abstract

A novel injectable-chitosan-based delivery system with low cytotoxicity was fabricated in the study. The chitosan microspheres with small particle size, low crystallinity and good sphericity were prepared by a spray-drying method followed by treating with a crosslinker. In the study, a naturally occurring crosslinking reagent (genipin), which has been used in herbal medicine and in the production of food dyes, was used to crosslink the chitosan microspheres. The glutaraldehyde-crosslinked counterparts were used as a control. Histological study of the genipin-crosslinked chitosan microspheres injected intramuscularly into the skeletal muscle of a rat model showed a less inflammatory reaction than its glutaraldehyde-crosslinked counterparts. The results of the scanning electron microscopic examination indicated that the glutaraldehyde-crosslinked chitosan microspheres retrieved at 12-week postoperatively were already degraded into a loose and porous structure. However, the degradation of the genipin-crosslinked chitosan microspheres was not significant after 20 weeks of implantation. The results of the study demonstrated that the genipin-crosslinked chitosan microspheres have a superior biocompatibility and a slower degradation rate than the glutaraldehyde-crosslinked chitosan microspheres. Accordingly, the genipin-crosslinked chitosan microspheres may be a suitable polymeric carrier for long-acting injectable drug delivery.

Original languageEnglish
Pages (from-to)181-191
Number of pages11
JournalBiomaterials
Volume23
Issue number1
DOIs
Publication statusPublished - Jan 1 2002
Externally publishedYes

Fingerprint

Chitosan
Biocompatibility
Microspheres
Injections
Glutaral
Cross-Linking Reagents
Degradation
Spray drying
Herbal Medicine
Cytotoxicity
Drug delivery
Particle Size
Crosslinking
Muscle
Rats
Microscopic examination
Skeletal Muscle
Coloring Agents
Dyes
Particle size

Keywords

  • Biocompatibility
  • Chitosan
  • Degradation
  • Genipin
  • Glutaraldehyde
  • Microspheres

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Biomedical Engineering

Cite this

In vivo biocompatibility and degradability of a novel injectable-chitosan-based implant. / Mi, Fwu Long; Tan, Yu Chiun; Liang, Hsiang F.; Sung, Hsing W.

In: Biomaterials, Vol. 23, No. 1, 01.01.2002, p. 181-191.

Research output: Contribution to journalArticle

Mi, Fwu Long ; Tan, Yu Chiun ; Liang, Hsiang F. ; Sung, Hsing W. / In vivo biocompatibility and degradability of a novel injectable-chitosan-based implant. In: Biomaterials. 2002 ; Vol. 23, No. 1. pp. 181-191.
@article{8b601cd6a3e54956875e3d90b653c180,
title = "In vivo biocompatibility and degradability of a novel injectable-chitosan-based implant",
abstract = "A novel injectable-chitosan-based delivery system with low cytotoxicity was fabricated in the study. The chitosan microspheres with small particle size, low crystallinity and good sphericity were prepared by a spray-drying method followed by treating with a crosslinker. In the study, a naturally occurring crosslinking reagent (genipin), which has been used in herbal medicine and in the production of food dyes, was used to crosslink the chitosan microspheres. The glutaraldehyde-crosslinked counterparts were used as a control. Histological study of the genipin-crosslinked chitosan microspheres injected intramuscularly into the skeletal muscle of a rat model showed a less inflammatory reaction than its glutaraldehyde-crosslinked counterparts. The results of the scanning electron microscopic examination indicated that the glutaraldehyde-crosslinked chitosan microspheres retrieved at 12-week postoperatively were already degraded into a loose and porous structure. However, the degradation of the genipin-crosslinked chitosan microspheres was not significant after 20 weeks of implantation. The results of the study demonstrated that the genipin-crosslinked chitosan microspheres have a superior biocompatibility and a slower degradation rate than the glutaraldehyde-crosslinked chitosan microspheres. Accordingly, the genipin-crosslinked chitosan microspheres may be a suitable polymeric carrier for long-acting injectable drug delivery.",
keywords = "Biocompatibility, Chitosan, Degradation, Genipin, Glutaraldehyde, Microspheres",
author = "Mi, {Fwu Long} and Tan, {Yu Chiun} and Liang, {Hsiang F.} and Sung, {Hsing W.}",
year = "2002",
month = "1",
day = "1",
doi = "10.1016/S0142-9612(01)00094-1",
language = "English",
volume = "23",
pages = "181--191",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier Science Ltd",
number = "1",

}

TY - JOUR

T1 - In vivo biocompatibility and degradability of a novel injectable-chitosan-based implant

AU - Mi, Fwu Long

AU - Tan, Yu Chiun

AU - Liang, Hsiang F.

AU - Sung, Hsing W.

PY - 2002/1/1

Y1 - 2002/1/1

N2 - A novel injectable-chitosan-based delivery system with low cytotoxicity was fabricated in the study. The chitosan microspheres with small particle size, low crystallinity and good sphericity were prepared by a spray-drying method followed by treating with a crosslinker. In the study, a naturally occurring crosslinking reagent (genipin), which has been used in herbal medicine and in the production of food dyes, was used to crosslink the chitosan microspheres. The glutaraldehyde-crosslinked counterparts were used as a control. Histological study of the genipin-crosslinked chitosan microspheres injected intramuscularly into the skeletal muscle of a rat model showed a less inflammatory reaction than its glutaraldehyde-crosslinked counterparts. The results of the scanning electron microscopic examination indicated that the glutaraldehyde-crosslinked chitosan microspheres retrieved at 12-week postoperatively were already degraded into a loose and porous structure. However, the degradation of the genipin-crosslinked chitosan microspheres was not significant after 20 weeks of implantation. The results of the study demonstrated that the genipin-crosslinked chitosan microspheres have a superior biocompatibility and a slower degradation rate than the glutaraldehyde-crosslinked chitosan microspheres. Accordingly, the genipin-crosslinked chitosan microspheres may be a suitable polymeric carrier for long-acting injectable drug delivery.

AB - A novel injectable-chitosan-based delivery system with low cytotoxicity was fabricated in the study. The chitosan microspheres with small particle size, low crystallinity and good sphericity were prepared by a spray-drying method followed by treating with a crosslinker. In the study, a naturally occurring crosslinking reagent (genipin), which has been used in herbal medicine and in the production of food dyes, was used to crosslink the chitosan microspheres. The glutaraldehyde-crosslinked counterparts were used as a control. Histological study of the genipin-crosslinked chitosan microspheres injected intramuscularly into the skeletal muscle of a rat model showed a less inflammatory reaction than its glutaraldehyde-crosslinked counterparts. The results of the scanning electron microscopic examination indicated that the glutaraldehyde-crosslinked chitosan microspheres retrieved at 12-week postoperatively were already degraded into a loose and porous structure. However, the degradation of the genipin-crosslinked chitosan microspheres was not significant after 20 weeks of implantation. The results of the study demonstrated that the genipin-crosslinked chitosan microspheres have a superior biocompatibility and a slower degradation rate than the glutaraldehyde-crosslinked chitosan microspheres. Accordingly, the genipin-crosslinked chitosan microspheres may be a suitable polymeric carrier for long-acting injectable drug delivery.

KW - Biocompatibility

KW - Chitosan

KW - Degradation

KW - Genipin

KW - Glutaraldehyde

KW - Microspheres

UR - http://www.scopus.com/inward/record.url?scp=0036027616&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036027616&partnerID=8YFLogxK

U2 - 10.1016/S0142-9612(01)00094-1

DO - 10.1016/S0142-9612(01)00094-1

M3 - Article

C2 - 11762837

AN - SCOPUS:0036027616

VL - 23

SP - 181

EP - 191

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

IS - 1

ER -